...We Welcome You To The Resverlogix HUB withIn The AGORACOM COMMUNITY!

Free
Message: Re: IR response
8
May 04, 2022 03:37PM
6
May 06, 2022 12:22AM
3
May 06, 2022 10:15AM
1
May 06, 2022 10:35AM

KOO - All patients are given standard of care so there is no disadvantage to participating in the trial. I don't know if the patients would know whether they were on the APB or placebo. Getting the safety information about APB could be the single biggest roadblock to having patients saying yes or no.

tada 

1
May 06, 2022 10:31PM
2
May 07, 2022 01:38AM
3
May 07, 2022 07:51PM
Share
New Message
Please login to post a reply